Organon wins FDA nod to expand use of Nexplanon birth control implant

Organon (OGN) has received FDA approval to expand the label of its birth control implant Nexplanon from its current three years to five years. Read more here.
Neurology Advisor

Nexplanon Approved for Pregnancy Prevention for Up to 5 Years

The FDA extended the duration of use of Nexplanon for pregnancy prevention in women of reproductive potential for up to 5 years.
Zacks Investment Research on MSN

Organon secures FDA approval extending NEXPLANON use to five years

Organon & Co. OGN recently announced that the FDA has approved a supplemental New Drug Application, extending the duration of ...
The American Journal of Managed Care

5 Birth Control Methods That Are Safe for Women to Use

Education on birth control and its potential adverse effects is vital to women choosing the type that best suits them. Skepticism surrounding hormonal birth control has been increasing nationwide, ...